Diet, Immunometabolism and Non-alcoholic Fatty Liver Disease
Non-Alcoholic Fatty Liver Disease, Liver Fat, Obesity
About this trial
This is an interventional treatment trial for Non-Alcoholic Fatty Liver Disease
Eligibility Criteria
Inclusion Criteria: Males and females Age 18-65 years, from all ethnic groups, capable of providing informed consent to participate Obesity (body mass index >30kg/m^2) and of stable body weight (±3% for ≥3 months) Fasting blood glucose <7.0 mmol/L and HbA1c <6.5%. Liver fat >10% (CAP score >238 dB/m) and no fibrosis (liver stiffness score 2-7 kPa) as assessed by liver elastography (FibroScan) Exclusion Criteria: Impaired renal function Abnormal hematocrit History of cardiovascular events Uncontrolled hypertension Type 2 diabetes Medications or supplements known to affect glucose or lipid metabolism Active inflammatory, autoimmune, infectious, gastrointestinal, or malignant disease Uncontrolled neurological or psychiatric disease Iron deficiency anemia, (hemoglobin < 12g/dl men, < 11g/dl women) Fatty acid supplements and consumers of high doses of anti- antioxidant vitamins (A, C, E, b-carotene)
Sites / Locations
- University College DublinRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
Standard healthy eating advice
eTRE plus Mediterranean diet
Subjects in this group will be counselled according to the Irish National Healthy Eating Guidelines.
Subjects in this group will be asked to restrict their eating to 8-hours daily (8am - 4pm) and to adhere to a Mediterranean style diet.